Ebola vaccine from Siberia to start clinical trials in August

Print 11 June 2015
Marchmont Innovation News

The best versions of Russia’s new vaccine to fight the Ebola virus will start clinical trials in August, the Russian news agency TASS  reported , citing the developers in Novosibirsk, in Siberia. 

“We have several versions, and research is fully under way. Some of these are prepared already, and we will start to send them for clinical trials very soon. One of the versions is ready for sending; two or three more are on their way,” said Valery Mikheyev, the acting CEO of the Novosibirsk-based Vektor state scientific center for virology and biotechnology. 

The developers will hand-pick the best version of the new vaccine in August, and the process will begin, he added. 

Since its outbreak more than a year ago the terrible Ebola epidemic has claimed 11,145 lives in the West African states of Guinea, Liberia and Sierra-Leone. Another 27,135 people have contracted the deadly disease, the World Health Organization reported.

Source

Return